Skip to main content

Table 2 EQ5D utility score and EQ-VAS score analysis

From: The effect of oral sildenafil therapy on health-related quality of life in adults with pulmonary arterial hypertension related to uncorrected secundum atrial septal defect: a quasi experimental study

Time EQ5D Utility Score
Median Minimum Maximum Z-score p
Before treatment 0.604 0.098 0.766 −2.703 0.007*
After treatment 0.664 0.393 0.798
Time EQ-VAS Score
Mean (SD) Difference (SD) Mean 95% CI p
Lower Upper
Before treatment 65 ± 13.06 6.67 ± 8.75 2.32 11.02 0.005*
After treatment 71.67 ± 15.53
  1. SD standard deviation, EQ5D EuroQoL-5 Dimensions, EQVAS EuroQoL-Visual Analogue Scale, *p < 0.05; 95% CI